Westside Investment Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$101K Buy
1,296
+96
+8% +$7.5K 0.02% 344
2025
Q1
$87K Hold
1,200
0.02% 325
2024
Q4
$88.8K Hold
1,200
0.02% 322
2024
Q3
$79.2K Hold
1,200
0.02% 339
2024
Q2
$111K Hold
1,200
0.03% 294
2024
Q1
$115K Hold
1,200
0.03% 281
2023
Q4
$91.5K Hold
1,200
0.02% 289
2023
Q3
$83.1K Hold
1,200
0.02% 292
2023
Q2
$113K Hold
1,200
0.03% 260
2023
Q1
$99.3K Hold
1,200
0.03% 275
2022
Q4
$89 Hold
1,200
﹤0.01% 366
2022
Q3
$99 Hold
1,200
﹤0.01% 358
2022
Q2
$114 Hold
1,200
﹤0.01% 340
2022
Q1
$141 Hold
1,200
﹤0.01% 341
2021
Q4
$155 Hold
1,200
﹤0.01% 320
2021
Q3
$135 Hold
1,200
﹤0.01% 318
2021
Q2
$124 Hold
1,200
﹤0.01% 323
2021
Q1
$100 Hold
1,200
﹤0.01% 328
2020
Q4
$109 Hold
1,200
﹤0.01% 285
2020
Q3
$95 Hold
1,200
﹤0.01% 302
2020
Q2
$82 Hold
1,200
﹤0.01% 296
2020
Q1
$75 Buy
+1,200
New +$75 ﹤0.01% 296
2019
Q2
$73 Buy
+1,200
New +$73 ﹤0.01% 278
2018
Q4
$61.3K Sell
1,200
-129
-10% -$6.59K 0.02% 269
2018
Q3
$14.2K Sell
1,329
-66
-5% -$704 ﹤0.01% 426
2018
Q2
$68K Hold
1,395
0.02% 267
2018
Q1
$63K Hold
1,395
0.03% 260
2017
Q4
$54.9K Hold
1,395
0.03% 271
2017
Q3
$51.3K Buy
1,395
+66
+5% +$2.43K 0.03% 266
2017
Q2
$52.1K Buy
1,329
+129
+11% +$5.05K 0.03% 260
2017
Q1
$37.2K Hold
1,200
0.02% 281
2016
Q4
$39.5K Buy
+1,200
New +$39.5K 0.03% 203